OXFORD IMMUNOTEC GLOBAL PLC 4,255,319 Ordinary Shares Underwriting AgreementLetter Agreement • February 4th, 2015 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances • New York
Oxford Immunotec Global PLC, a public limited company incorporated under the laws of England and Wales (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 4,255,319 ordinary shares, £0.006705 nominal value per share, of the Company (the “Underwritten Shares”). In addition, solely for the purpose of covering overallotments, the Company proposes to issue and sell, at the option of the Underwriters, up to an additional 638,297 ordinary shares of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The ordinary shares of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Ordinary Shares.”
